Anti-SEZ6L2 Antibody-Associated Autoimmune Encephalitis Mimicking Acute Stroke: A Case Report with Literature Review

The Brain's Glitchy Security System

Imagine your body is a bustling city, and your immune system is the tireless police force. Its job is to spot and stop invaders like bacteria or viruses that try to break in. Usually, the police are very good at their job, distinguishing between a harmless tourist and a dangerous criminal. But sometimes, the police get confused. They start seeing regular citizens as enemies. This mix-up is called an autoimmune disorder. Instead of just fighting germs, the body's defense system accidentally attacks its own healthy tissues.

When this confusion happens inside the brain, it's called autoimmune encephalitis. The brain is the city's command center, and if the police start arresting the neurons (the brain's messengers) or the connections between them, the whole city starts to malfunction. You might see memory loss, seizures, or trouble moving. For a long time, doctors thought these strange symptoms were caused by a stroke (a traffic jam in the brain's blood vessels) or a slow-decaying disease like Alzheimer's. But recently, scientists discovered a new "suspect": a specific type of antibody (a police badge) that targets a protein called SEZ6L2. This protein is like a special lock on the surface of brain cells, mostly in the area that controls balance and coordination (the cerebellum). When the wrong antibodies attack this lock, the brain's balance center goes haywire. The big question is: How do we tell the difference between a brain glitch caused by a blood clot and one caused by a confused immune system, especially when they look exactly the same?

The Case of the "Stroke" That Wasn't

This paper tells the story of a 53-year-old woman who walked into a hospital thinking she had a stroke. She suddenly started having trouble speaking clearly and her walk became unsteady, like she was on a boat. Because she also had a small hole in her heart (called a Patent Foramen Ovale, or PFO), doctors assumed a tiny blood clot had traveled from her heart to her brain. They treated her for a stroke: they gave her blood thinners, closed the hole in her heart, and tried to improve her blood flow. But nothing worked. In fact, her condition got worse. She started having seizures, her memory faded, and she developed strange psychiatric symptoms.

The doctors at Renji Hospital in Shanghai decided to look deeper. They realized this wasn't a simple traffic jam; it was a case of mistaken identity. They tested her blood and spinal fluid and found a smoking gun: Anti-SEZ6L2 antibodies. Her immune system had created 1,000 units of these specific antibodies in her blood and 100 units in her spinal fluid, all attacking her brain's balance center. The paper confirms that her "stroke" was actually a rare form of Autoimmune Encephalitis caused by these antibodies. The hole in her heart was a red herring—a distraction that led to a wrong diagnosis.

What the Study Found

The authors didn't just stop at this one patient. They gathered data from 24 other cases around the world to see if this was a pattern. Here is what they discovered:

• Who gets sick? It mostly happens to middle-aged and older women. In their group, 70.83% of the patients were female, and the average age was about 60 years.
• What are the symptoms? Almost everyone (95.83%) had trouble with balance (cerebellar ataxia), and most (75%) had trouble speaking (dysarthria). As the disease progressed, many developed memory issues, seizures, or trouble with their eyes.
• The "Stroke" Trap: A major finding is that this disease often looks exactly like a stroke. In fact, this specific patient was misdiagnosed with a stroke multiple times. The paper argues that if a patient has "stroke-like" symptoms that don't get better with standard stroke treatment, doctors should immediately check for these specific antibodies.
• The Cancer Connection: The paper notes that in 12.50% of the cases, the autoimmune attack was linked to a hidden cancer (a paraneoplastic syndrome). The patient in this story had a history of cervical cancer treated over a decade ago. The authors suggest that the cancer and its treatment might have confused her immune system, causing it to attack her brain years later.
• Does it get better? The outlook is mixed. After trying different treatments, only 58.33% of patients saw mild improvement. Some got worse, and sadly, one patient passed away. The paper suggests that the key to a better outcome is catching it early and using a "cocktail" of treatments, not just one.

How They Tried to Fix It

Treating this condition is like trying to stop a riot in the city. The doctors used a step-by-step approach:

1. Wash the system: They used a machine called double-filtration plasmapheresis to filter the blood, physically removing the bad antibodies.
2. Stop the production: They gave the patient Rituximab (a drug that stops the immune cells from making new antibodies) and Mycophenolate mofetil (to calm down the immune system).
3. Control the chaos: They used anti-seizure medications to stop the brain from firing wildly.

The patient's condition stabilized after this combined approach, but she still had some lingering problems with her balance and thinking. The paper emphasizes that because this disease is rare and tricky, there is no single "magic bullet" yet. Doctors need to be ready to combine different therapies and keep a close eye on patients for years to make sure the cancer doesn't come back and the antibodies don't return.

The Bottom Line

This paper is a warning and a guide. It tells doctors: "If you see a patient who looks like they had a stroke but isn't getting better, don't just assume it's a blood clot. Check for Anti-SEZ6L2 antibodies." It highlights that the brain's immune system can get confused and attack its own balance center, mimicking a stroke. While the disease is rare and the cure isn't perfect yet, catching it early and using a mix of treatments gives patients the best chance to recover. The story of this woman shows that sometimes, the answer to a medical mystery isn't a new drug, but a new way of looking at the clues.